12-Hour area under the curve cyclosporine concentrations determined by a validated liquid chromatography-mass spectrometry procedure compared with fluorescence polarization immunoassay reveals sirolimus effect on cyclosporine pharmacokinetics

Therapeutic Drug Monitoring

Volumn 28, Issue 6, 2006, Pages 726-736

  Napoli, Kimberly L ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Area under the curve; Cyclosporine; Fluorescence polarization immunoassay; Liquid chromatography with mass spectrometric detection; Liquid chromatography with mass spectrometric detection with a single quadrupole instrument

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN D; RAPAMYCIN;

AREA UNDER THE CURVE; COMPARATIVE STUDY; CONFERENCE PAPER; DOSE RESPONSE; DRUG BLOOD LEVEL; FLUORESCENCE POLARIZATION IMMUNOASSAY; GRAFT RECIPIENT; HUMAN; KIDNEY TRANSPLANTATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NORMAL HUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VALIDATION PROCESS;

AREA UNDER CURVE; CHROMATOGRAPHY, LIQUID; CYCLOSPORINE; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMANS; KIDNEY TRANSPLANTATION; MALE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SIROLIMUS; TANDEM MASS SPECTROMETRY;

EID: 33845718539     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ftd.0000249951.58504.0e     Document Type: Conference Paper

References (34)

1. Christians U, Jacobsen W, Serkova N, et al. Automated, fast and sensitive quantification of drugs in blood by liquid chromatography-mass spectrometry with on-line extraction: immunosuppressants. J Chromatog B. 2000;748:41-53.
2. McMahon LM, Luo S, Hayes M, et al. High-throughput analysis of everolimus (RAD001) and cyclosporin A (CsA) in whole blood by liquid chromatography/mass spectrometry using a semi-automated 96-well solid-phase extraction system. Rapid Commun Mass Spectrom. 2000;14:1965-1971.
3. Volosov A, Napoli KL, Soldin SJ. Simultaneous simple and fast quantification of three major immunosuppressants by liquid chromatography-tandem mass-spectrometry. Clin Biochem. 2001;34:285-290.
4. Zhou S, Tan D, Theng J, et al. Optimized analytical method for cyclosporin A by high performance liquid chromatography-electrospray ionization mass spectrometry. J Chromatog B. 2001;754:201-207.
5. Keevil BG, Tierney DP, Cooper DP, et al. Rapid liquid chromatography-tandem mass spectrometry method for routine analysis of cyclosporin A over an extended concentration range. Clin Chem. 2002;48:69-76.
6. Deters M, Kirchner G, Resch K, et al. Simultaneous quantification of sirolimus, everolimus, tacrolimus and cyclosporine by liquid chromatography-mass spectrometry (LC-MS). Clin Chem Lab Med. 2002:40:285-292.
7. Streit F, Armstrong VM, Oellerich M. Rapid liquid chromatography-tandem lass spectrometry routine method for simultaneous determination of sirolimus, everolimus, tacrolimus and cyclosporin A in whole blood. Clin Chem. 2002;48:955-958.
8. Koal T, Deters M, Casetta B, et al. Simultaneous determination of four immunosuppressants by means of high speed and robust on-line solid phase extraction-high performance liquid chromatography-tandem mass spectrometry. J Chromatog B. 2005;805:215-222.
9. Annesley TM, Clayton L. Simple extraction protocol for analysis of immunosuppressants in whole blood. Clin Chem. 2004;50:1845-1848.
10. Poquette MA, Lensmeyer GL, Doran TC. Effective use of liquid chromatography-mass spectrometry (LC/MS) in the routine clinical laboratory for monitoring sirolimus, tacrolimus and cyclosporine. Ther Drug Monit. 2005;27:144-150.
11. Salm P, Taylor PJ, Lynch SV, et al. A rapid HPLC-mass spectrometry cyclosporin method suitable for current monitoring practices. Clin Biochem. 2005;38:667-673.
12. Taylor PJ, Brown SR, Cooper DP, et al. Evaluation of 3 internal standards for the measurement of cyclosporine by HPLC-mass spectrometry. Clin Chem. 2005;51:1890-1893.
13. Wang P. Meucci E, Simpson E, et al. A monoclonal antibody fluorescent polarization immunoassay for cyclosporine. Transplant Proc. 1990;22:1186-1888.
14. Yatscoff RW, Copeland KR, Faraci CJ. Abbott TDx monoclonal antibody assay evaluated for measuring cyclosporine in whole blood. Clin Chem. 1990;36:1969-1973.
15. Schütz E, Streit F, Dias VC, et al. CsA immunoassays in comparison to LC-MS/MS, is there a difference between trough (C0) and C2 levels? Ther Drug Monit. 2001;23:471.
16. Dusci LJ, Hacket P, chiswell GM, et al. Comparison of cyclosporine measurement in whole blood by high-performance liquid chromatography, monoclonal fluorescence polarization immunoassay, and monoclonal enzyme-multiplied immunoassay. Ther Drug Monit. 1992;14:327-332.
17. McBride JH, Kim SS, Rodgerson DO, et al. Measurement of cyclosporine by liquid chromatography and three immunoassays in blood from liver, cardiac, and renal transplants. Clin Chem. 1992;38:2300-2306.
18. Taylor PJ, Salm P, Norris RL, et al. Comparison of high-performance liquid chromatography and monoclonal fluorescence polarization immunoassay for the determination of whole-blood cyclosporin A in liver and heart transplant patients. Ther Drug Monit. 1994;16:526-530.
19. Schütz E, Svinarov D, Shipkova M, et al. cyclosporin whole blood immunoassays (AxSYM, CEDIA, and EMIT): a critical overview of performance characteristics and comparison with HPLC. Clin Chem. 1998;44:2158-2164.
20. Kaplan B, Meier-Kriesche HU, Napoli KL. The effects of relative timing of sirolimus and cyclosporine microemulsion formulation co-administration on the pharmacokinetics of each agent. Clin Pharmacol Ther. 1998;63:48-53.
21. Tacrolimus International Proficiency Testing Scheme. Available at: www.bioanlaytics.co.uk. Accessed April 14, 2006.
22. College of American Pathologists Immunosuppressive Drugs Survey. Available at: www.cap.org. Accessed April 14, 2006.
23. Center for Veterinary Medicine, Center for Drug Evaluation and Research, Food and Drug Administration, US Department of Health and Human Services. Guidance for Industry: Bioanalytical Method Validation. Available at: www.fda.gov/cder/guidance/4252fnl.pdf. Accessed July 21, 2005.
24. Streit F, Armstrong VW, Oellerich M. Mass interferences in quantification of cyclosporine using tandem mass spectrometry without chromatography. Ther Drug Monit. 2003;25:506.
25. Cyclosporine Monoclonal Whole Blood TDx/TDxFLx Package Insert. Abbott Park, IL: Abbott Laboratories, 2005.
26. th ed. Belmont, CA: Wadsworth Publishing Company, 1995:279-280.
27. Johnston A, Chusney G, Schütz E, et al. Monitoring cyclosporin in blood: between-assay differences at trough and 2 hours post-dose (C2). Ther Drug Monit. 2003;25:167-173.
28. Oellerich M, Armstrong VW, Kahan B, et al. Lake Louise consensus conference on cyclosporin monitoring in organ transplantation: report of the consensus panel. Ther Drug Monit. 1995;17:642-654.
29. Oellerich M, Armstrong VW, Schütz E, et al. Therapeutic drug monitoring of cyclosporine and tacrolimus: update of Lake Louise consensus conference on cyclosporine and tacrolimus. Clin Biochem. 1998;31:309-316.
30. Steimer W. Performance and specificity of monoclonal immunoassays for cyclosporine monitoring: How specific is specific? Clin Chem. 1999;45:371-381.
31. Holt DW, Johnston A, Kahan BD, et al. New approaches to cyclosporine monitoring raise further concerns about analytical techniques. Clin Chem. 2000;46:872-875.
32. Soldin SJ, Steele BW, Witte DL, et al. Lack of specificity of cyclosporine immunoassays, Results of a College of American Pathologists study. Arch Pathol Lab Med. 2003;127:19-22.
33. Morris RG, Holt DW, Armstrong VW, et al. Analytic aspects of cyclosporine monitoring, on behalf of the IFCC/IATDMCT joint working group. Ther Drug Monit. 2004;26:227-230.
34. Amante AJ, Kahan BD. Abbreviated area under-the-curve strategy for monitoring cyclosporine microemulsion therapy in immediate posttransplant period. Clin Chem. 1996;42:1294-1296.